4//SEC Filing
Icagen, Inc. 4
Accession 0001213900-17-003812
CIK 0001518520operating
Filed
Apr 13, 8:00 PM ET
Accepted
Apr 14, 4:25 PM ET
Size
7.0 KB
Accession
0001213900-17-003812
Insider Transaction Report
Form 4
Icagen, Inc.NONE
Palmieri Vincent
Director
Transactions
- Award
Warrant
2017-04-13+6,000→ 6,000 totalExercise: $3.50From: 2017-04-13Exp: 2022-04-12→ Common Stock (6,000 underlying)
Footnotes (2)
- [F1]Icagen, Inc. (the "Company") issued units (the "Units" and each a "Unit") in a private placement offering (the "Offering") with each Unit consisting of (i) a note in the principal amount of $10,000, and (ii) a five- year warrant to acquire 1,500 shares of Common Stock, at an exercise price of $3.50 per share. The Company retained Taglich Brothers, Inc. as the exclusive placement agent (the "Placement Agent") for the Offering.
- [F2]As compensation for the Placement Agent's services in the Offering, the Company (i) paid the Placement Agent a cash commission on the gross proceeds raised in the Offering (excluding amounts invested by the Company's Chairman of the Board), and (ii) issued the Placement Agent the same warrant that the investors received in the Offering exercisable for an aggregate amount of 25,000 shares of the Company's common stock, par value, $0.001 per share ("Common Stock" ) at an exercise price of $3.50 per share (2,500 shares of Common Stock for each $100,000 in principal amount of notes sold, excluding notes sold to the Chairman of the Board). The reporting person received these warrants as the designee of the Placement Agent. The reporting person has the right to exchange these warrants, which were assigned to him by the Placement Agent, for a like number of warrants to be issued to the lender in the Company's next debt financing.
Documents
Issuer
Icagen, Inc.
CIK 0001518520
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001518520
Filing Metadata
- Form type
- 4
- Filed
- Apr 13, 8:00 PM ET
- Accepted
- Apr 14, 4:25 PM ET
- Size
- 7.0 KB